home.social

#neuronatherapeutics — Public Fediverse posts

Live and recent posts from across the Fediverse tagged #neuronatherapeutics, aggregated by home.social.

  1. UCB’s $1.15B Neurona Therapeutics acquisition is a high-stakes bet on cell therapy in epilepsy. The bigger question: can biotech move from suppressing seizures to repairing brain circuits?

    biotech.industryexaminer.com/u
    #Biotech #UCB #NeuronaTherapeutics #Epilepsy #CellTherapy #TechNews

  2. UCB’s $1.15B Neurona Therapeutics acquisition is a high-stakes bet on cell therapy in epilepsy. The bigger question: can biotech move from suppressing seizures to repairing brain circuits?

    biotech.industryexaminer.com/u
    #Biotech #UCB #NeuronaTherapeutics #Epilepsy #CellTherapy #TechNews

  3. UCB’s $1.15B Neurona Therapeutics acquisition is a high-stakes bet on cell therapy in epilepsy. The bigger question: can biotech move from suppressing seizures to repairing brain circuits?

    biotech.industryexaminer.com/u
    #Biotech #UCB #NeuronaTherapeutics #Epilepsy #CellTherapy #TechNews

  4. UCB’s $1.15B Neurona Therapeutics acquisition is a high-stakes bet on cell therapy in epilepsy. The bigger question: can biotech move from suppressing seizures to repairing brain circuits?

    biotech.industryexaminer.com/u
    #Biotech #UCB #NeuronaTherapeutics #Epilepsy #CellTherapy #TechNews

  5. UCB’s $1.15B Neurona Therapeutics acquisition is a high-stakes bet on cell therapy in epilepsy. The bigger question: can biotech move from suppressing seizures to repairing brain circuits?

    biotech.industryexaminer.com/u
    #Biotech #UCB #NeuronaTherapeutics #Epilepsy #CellTherapy #TechNews